Speaker Details

April W. Armstrong, MD, MPH, FAAD

April W. Armstrong, MD, MPH, FAAD

University of California Los Angeles

BIOGRAPHY

Dr. April Armstrong is Professor and Chief of Dermatology at University of California Los Angeles (UCLA). She is an internationally renowned dermatologist and clinical researcher with expertise in inflammatory skin diseases. Dr. Armstrong is a federally funded investigator whose research focuses on (1) evaluating novel systemic and topical therapies for inflammatory skin diseases, (2) identifying treatment goals and comorbidities associated with skin diseases, and (3) increasing patient access using innovative, technology-enabled healthcare delivery methods. Dr. Armstrong has conducted over 150 clinical trials and published over 600 articles in scientific journals. Dr. Armstrong is also a passionate educator, having mentored numerous medical students, residents, and postdoctoral research fellows. She has received institutional and national teaching awards for her educational efforts. Dr. Armstrong has a long history of service to the medical profession on a national and international level. She has served as a board member of the American Academy of Dermatology, Chair Emeritis of the Medical Board at the National Psoriasis Foundation, Past Co-President of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), councilor for the International Eczema Council and International Psoriasis Council, and a board member for the International Dermatology Outcome Measures and the California Society of Dermatology and Dermatological Surgery (CalDerm). She is also an editorial board member of JAMA Dermatology and had also served on the editorial boards of JAAD and other journals.

SESSIONS

S023 Late-Breaking Research: Session 1
Mar 28, 2026 9:00 AM - 12:00 PM Bellco Theatre
S034 Late-Breaking Research: Session 2
Mar 28, 2026 1:00 PM - 4:00 PM Bellco Theatre
S035 Therapeutic Hotline
Mar 28, 2026 1:00 PM - 4:00 PM Bluebird 1B
S043 Psoriasis
Mar 29, 2026 1:00 PM - 4:00 PM Four Seasons 3
S065 What's New in Dermatology
Mar 31, 2026 10:15 AM - 12:15 PM Four Seasons 1

DISCLOSURES

AbbVie – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Amgen – Advisory Board(Honoraria); Arcutis Biotherapeutics – Consultant(Honoraria); Boehringer Ingelheim – Data Safety Monitoring Board(Honoraria); Bristol-Myers Squibb – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Dermavant Sciences, Inc. – Consultant(Honoraria); Dermsquared – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria); Galderma USA – Advisory Board(Honoraria); Incyte – Consultant (1099 relationship)(Honoraria); Janssen Biotech – Consultant (1099 relationship)(Honoraria); Leo Pharma Inc – Consultant(Honoraria); Novartis – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Ortho Dermatologics – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Regeneron – Advisory Board(Honoraria); Sanofi Genzyme – Consultant(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria);